Ian Lauf

Ian Lauf, MBA has extensive experience in clinical contracts and outsourcing within the biotechnology and pharmaceutical industry. Ian is currently serving as the Senior Director of Clinical Contracts & Outsourcing at Sana Biotechnology, Inc. Their previous roles include Executive Director of R&D Strategic Outsourcing at Exelixis, Executive Director of Clinical Contracts & Outsourcing at Intercept Pharmaceuticals, and Director of Clinical Business Operations at Shionogi Inc. Prior to these positions, Ian founded and served as CEO of ClinSource Global, Inc. Ian also held various leadership roles at Eisai US, including US Head of Global Clinical Outsourcing and Global Head of Clinical Alliance Management. Overall, Ian Lauf's expertise lies in strategic outsourcing, alliance management, and clinical contracts within the biotech and pharma sectors.

Ian Lauf, MBA received their Master of Business Administration (MBA) degree in Pharmaceutical Business from the University of the Sciences in Philadelphia, where they studied from 2002 to 2005. Prior to that, Ian completed their Bachelor of Science (BS) degree in Public Health from Stockton University, from 1996 to 2000.